Stonepine Capital Management, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,835,000
-62.2%
1,540,671
-55.8%
1.27%
-63.5%
Q2 2022$7,499,000
-43.4%
3,487,928
-17.3%
3.49%
-36.5%
Q1 2022$13,245,000
+3.0%
4,218,069
+5.3%
5.49%
-6.9%
Q4 2021$12,860,000
+17.7%
4,006,185
+23.2%
5.90%
+18.6%
Q3 2021$10,930,000
+39.8%
3,252,892
+62.6%
4.97%
+21.6%
Q2 2021$7,820,000
-21.7%
2,000,000
-19.5%
4.09%
-24.2%
Q1 2021$9,982,0002,483,0595.39%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders